Abhishek Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abhishek Pandey has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Girardin Jean-Louis
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, USA
11 shared publications G. Ogedegbe
Center for Healthful Behavior Change
3 shared publicationsM. Demede
Division of Cardiovascular Medicine, Department of Medicine SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203-2098, USA
3 shared publicationsS. I. McFarlane
Division of Endocrinology, Diabetes, and Hypertension
3 shared publicationsF. Zizi
Brooklyn Center for Health Disparities, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, P.O. Box 1199, Brooklyn, NY 11203-2098, USA
2 shared publicationsFerdinand Zizi
Brooklyn Health Disparities Center, Department of Medicine, SUNY Downstate Medical Center, NY
2 shared publications
Latest Publications
- Open Access
- 29 March 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 290
Associations between inadequate sleep and obesity in the US adult population: analysis of the national health interview survey (1977–2009)
Epidemiologic studies show a curvilinear relationship between inadequate sleep (< 7 or > 8 hours) and obesity (Body Mass Index > 30 kg/m2), which have enormous public health impact.
- 29 March 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 290
Open AccessAssociations between inadequate sleep and obesity in the US adult population: analysis of the national health interview survey (1977–2009)
Epidemiologic studies show a curvilinear relationship between inadequate sleep (< 7 or > 8 hours) and obesity (Body Mass Index > 30 kg/m2), which have enormous public health impact.
- Open Access
- 1 March 2014
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 8, 283-7
Excessive daytime sleepiness and adherence to antihypertensive medications among Blacks: analysis of the counseling African Americans to control hypertension (CAATCH) trial
Background: Excessive daytime sleepiness (EDS) often occurs as a result of insufficient sleep, sleep apnea, illicit substance use, and other medical and psychiatric conditions. This study tested the hypothesis that blacks exhibiting EDS would have poorer self-reported adherence to hypertensive medication using cross-sectional data from the Counseling African-Americans to Control Hypertension (CAATCH) trial. Methods: A total of 1,058 hypertensive blacks (average age 57±12 years) participated in CAATCH, a randomized controlled trial evaluating the effectiveness of a multilevel intervention for participants who receive care from community health centers in New York City. Data analyzed in this study included baseline sociodemographics, medical history, EDS, and medication adherence. We used the Epworth Sleepiness Scale, with a cutoff score of ≥10, to define EDS. Medication adherence was measured using an abbreviated Morisky Medication Adherence scale, with a score >0 indicating nonadherence. Results: Of the sample, 71% were female, 72% received at least a high school education, 51% reported a history of smoking, and 33% had a history of alcohol consumption. Overall, 27% of the participants exhibited EDS, and 44% of those who exhibited EDS were classified as adherent to prescribed antihypertensive medications. Multivariable logistic regression analysis, adjusting for effects of age, body mass index, sex, education, and smoking and drinking history indicated that participants who exhibited EDS were more than twice as likely to be nonadherent (odds ratio 2.28, 95% confidence interval 1.42–3.67, PConclusion: Analysis of the CAATCH data showed a high prevalence of EDS among hypertensive blacks. EDS is a significant predictor of nonadherence to prescribed medications for hypertension. These findings point to a modifiable variable that can be targeted in future interventions focusing on medication adherence.
- 1 March 2014
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 8, 283-7
Open AccessExcessive daytime sleepiness and adherence to antihypertensive medications among Blacks: analysis of the counseling African Americans to control hypertension (CAATCH) trial
Background: Excessive daytime sleepiness (EDS) often occurs as a result of insufficient sleep, sleep apnea, illicit substance use, and other medical and psychiatric conditions. This study tested the hypothesis that blacks exhibiting EDS would have poorer self-reported adherence to hypertensive medication using cross-sectional data from the Counseling African-Americans to Control Hypertension (CAATCH) trial. Methods: A total of 1,058 hypertensive blacks (average age 57±12 years) participated in CAATCH, a randomized controlled trial evaluating the effectiveness of a multilevel intervention for participants who receive care from community health centers in New York City. Data analyzed in this study included baseline sociodemographics, medical history, EDS, and medication adherence. We used the Epworth Sleepiness Scale, with a cutoff score of ≥10, to define EDS. Medication adherence was measured using an abbreviated Morisky Medication Adherence scale, with a score >0 indicating nonadherence. Results: Of the sample, 71% were female, 72% received at least a high school education, 51% reported a history of smoking, and 33% had a history of alcohol consumption. Overall, 27% of the participants exhibited EDS, and 44% of those who exhibited EDS were classified as adherent to prescribed antihypertensive medications. Multivariable logistic regression analysis, adjusting for effects of age, body mass index, sex, education, and smoking and drinking history indicated that participants who exhibited EDS were more than twice as likely to be nonadherent (odds ratio 2.28, 95% confidence interval 1.42–3.67, PConclusion: Analysis of the CAATCH data showed a high prevalence of EDS among hypertensive blacks. EDS is a significant predictor of nonadherence to prescribed medications for hypertension. These findings point to a modifiable variable that can be targeted in future interventions focusing on medication adherence.
- 1 August 2013
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 17 (4) , 255-262
Sleep in America: Role of racial/ethnic differences
- 1 August 2013
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 17 (4) , 255-262
Sleep in America: Role of racial/ethnic differences
- 1 May 2013
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 36 (5) , 769-779
Extreme Sleep Durations and Increased C-Reactive Protein: Effects of Sex and Ethnoracial Group
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 May 2013
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 36 (5) , 769-779
Extreme Sleep Durations and Increased C-Reactive Protein: Effects of Sex and Ethnoracial Group
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- Open Access
- 1 January 2013
- Published by Wiley in International Journal of Hypertension
- Vol. 2013, 1-7
Linking Sleep to Hypertension: Greater Risk for Blacks
Background. Evidence suggests that insufficient sleep duration is associated with an increased likelihood for hypertension. Both short (8 hour) sleep durations as well as hypertension are more prevalent among blacks than among whites. This study examined associations between sleep duration and hypertension, considering differential effects of race and ethnicity among black and white Americans.Methods. Data came from a cross-sectional household interview with 25,352 Americans (age range: 18–85 years).Results. Both white and black short sleepers had a greater likelihood of reporting hypertension than those who reported sleeping 6 to 8 hours. Unadjusted logistic regression analysis exploring the race/ethnicity interactions between insufficient sleep and hypertension indicated that black short (8 hours) sleepers were more likely to report hypertension than their white counterparts (OR = 1.34 and 1.37, resp.;). Significant interactions of insufficient sleep with race/ethnicity were observed even after adjusting to effects of age, sex, income, education, body mass index, alcohol use, smoking, emotional distress, diabetes, coronary heart disease, and stroke.Conclusion. Results suggest that the race/ethnicity interaction is a significant mediator in the relationship between insufficient sleep and likelihood of having a diagnosis of hypertension.- 1 January 2013
- Published by Wiley in International Journal of Hypertension
- Vol. 2013, 1-7
Open AccessLinking Sleep to Hypertension: Greater Risk for Blacks
Background. Evidence suggests that insufficient sleep duration is associated with an increased likelihood for hypertension. Both short (8 hour) sleep durations as well as hypertension are more prevalent among blacks than among whites. This study examined associations between sleep duration and hypertension, considering differential effects of race and ethnicity among black and white Americans.Methods. Data came from a cross-sectional household interview with 25,352 Americans (age range: 18–85 years).Results. Both white and black short sleepers had a greater likelihood of reporting hypertension than those who reported sleeping 6 to 8 hours. Unadjusted logistic regression analysis exploring the race/ethnicity interactions between insufficient sleep and hypertension indicated that black short (8 hours) sleepers were more likely to report hypertension than their white counterparts (OR = 1.34 and 1.37, resp.;). Significant interactions of insufficient sleep with race/ethnicity were observed even after adjusting to effects of age, sex, income, education, body mass index, alcohol use, smoking, emotional distress, diabetes, coronary heart disease, and stroke.Conclusion. Results suggest that the race/ethnicity interaction is a significant mediator in the relationship between insufficient sleep and likelihood of having a diagnosis of hypertension. - 18 April 2012
- Published by S. Karger AG in Cardiorenal Medicine
- Vol. 2 (2) , 143-162
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Numerous epidemiological studies confirm that the prevalence of obesity and the cardiorenal metabolic syndrome (CRS) is extraordinarily high and that the rates have increased dramatically in the last three decades. In addition, epidemiological data demonstrate that obesity, the CRS, and diabetes are inextricably linked and are all associated with an increased incidence of a number of solid tissue cancers. The mechanisms for this association have been examined, including, but not limited to, higher levels of insulin and free levels of insulin-like growth factor and insulin resistance in obesity and the CRS. Mortality, morbidity, and the associated health care costs which are the link between obesity, the CRS, and diabetes are just beginning to be examined. In addition, we review the advantages of implementing lifestyle and surgical changes to modify obesity, lessening the development of the CRS, diabetes, and associated cancers. Epidemiological data regarding the general mechanisms of the pathogenesis of cancers associated with obesity, the CRS, and diabetes (specifically colon, pancreas, esophageal, liver, breast, prostate, thyroid, and renal carcinomas) are reviewed. The mechanisms by which obesity and other components of the CRS contribute to the pathogenesis of these cancers, such as hormone alterations and insulin- and insulin-like growth factor-dependent pathways of tumor pathogenesis, include the attending roles of inflammation and oxidative stress. Emphasis has been placed on obesity as a modifiable risk factor which, when addressed, provides a reduction in the rate of cancer deaths. In a second part to be published in the next issue of this journal, the relationship between diabetes and cancer will be reviewed in detail.
- 18 April 2012
- Published by S. Karger AG in Cardiorenal Medicine
- Vol. 2 (2) , 143-162
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Numerous epidemiological studies confirm that the prevalence of obesity and the cardiorenal metabolic syndrome (CRS) is extraordinarily high and that the rates have increased dramatically in the last three decades. In addition, epidemiological data demonstrate that obesity, the CRS, and diabetes are inextricably linked and are all associated with an increased incidence of a number of solid tissue cancers. The mechanisms for this association have been examined, including, but not limited to, higher levels of insulin and free levels of insulin-like growth factor and insulin resistance in obesity and the CRS. Mortality, morbidity, and the associated health care costs which are the link between obesity, the CRS, and diabetes are just beginning to be examined. In addition, we review the advantages of implementing lifestyle and surgical changes to modify obesity, lessening the development of the CRS, diabetes, and associated cancers. Epidemiological data regarding the general mechanisms of the pathogenesis of cancers associated with obesity, the CRS, and diabetes (specifically colon, pancreas, esophageal, liver, breast, prostate, thyroid, and renal carcinomas) are reviewed. The mechanisms by which obesity and other components of the CRS contribute to the pathogenesis of these cancers, such as hormone alterations and insulin- and insulin-like growth factor-dependent pathways of tumor pathogenesis, include the attending roles of inflammation and oxidative stress. Emphasis has been placed on obesity as a modifiable risk factor which, when addressed, provides a reduction in the rate of cancer deaths. In a second part to be published in the next issue of this journal, the relationship between diabetes and cancer will be reviewed in detail.
- 1 February 2012
- Published by Elsevier in The American Journal of Medicine
- Vol. 125 (2) , 162-167
Race/Ethnicity, Sleep Duration, and Diabetes Mellitus: Analysis of the National Health Interview Survey
- 1 February 2012
- Published by Elsevier in The American Journal of Medicine
- Vol. 125 (2) , 162-167
Race/Ethnicity, Sleep Duration, and Diabetes Mellitus: Analysis of the National Health Interview Survey
- 30 September 2011
- Published by Elsevier in Sleep Medicine
- Vol. 12, S92
T-O-129 RACE/ETHNICITY, SLEEP DURATION, AND QUALITY OF LIFE: ANALYSIS OF THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM
- 30 September 2011
- Published by Elsevier in Sleep Medicine
- Vol. 12, S92
T-O-129 RACE/ETHNICITY, SLEEP DURATION, AND QUALITY OF LIFE: ANALYSIS OF THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM
- 30 September 2011
- Published by Elsevier in Sleep Medicine
- Vol. 12, S77
T-I-071 SHORT SLEEP AND DYSFUNCTIONAL BELIEFS AND ATTITUDES TOWARD SLEEP AMONG BLACK MEN
- 30 September 2011
- Published by Elsevier in Sleep Medicine
- Vol. 12, S77
T-I-071 SHORT SLEEP AND DYSFUNCTIONAL BELIEFS AND ATTITUDES TOWARD SLEEP AMONG BLACK MEN
- 1 September 2011
- Vol. 36 (3) , 187-209
Diabetes mellitus and the risk of cancer
Although diabetes has been known to increase the risk of cancer for over a century, it was not until recently when this area gained momentum and generated a lot of interest. That is in- part because of the rising global diabetes epidemic and the wide spread use of insulin analogues, metformin and other anti-diabetic agents, providing hypothesis generating data on the cancer risk in the diabetic population. Type 2 diabetes is associated with increased risk of breast, colon, pancreatic and other types of cancer, while type 1 diabetes is associated with increase in stomach, pancreatic, endometrial and cervical cancer. Mechanisms postulated for increased cancer risk in diabetes include hyperglycemia, hyperinsulinemia with stimulation of IGF-1 axis, obesity that serves as a common soil hypothesis for both cancer and diabetes as well as other factors such as increased cytokine production. More recently some antidiabetic agents have been thought to increase cancer risk such as insulin glargine, while metformin appears to lower cancer risk. In this review, we present the evidence for the link between diabetes and cancer highlighting the general mechanisms proposed for such a link as well as specific hypotheses for individual cancer. We will also discuss the role of insulin, metformin and other antidiabetic agents in cancer risk.
- 1 September 2011
- Vol. 36 (3) , 187-209
Diabetes mellitus and the risk of cancer
Although diabetes has been known to increase the risk of cancer for over a century, it was not until recently when this area gained momentum and generated a lot of interest. That is in- part because of the rising global diabetes epidemic and the wide spread use of insulin analogues, metformin and other anti-diabetic agents, providing hypothesis generating data on the cancer risk in the diabetic population. Type 2 diabetes is associated with increased risk of breast, colon, pancreatic and other types of cancer, while type 1 diabetes is associated with increase in stomach, pancreatic, endometrial and cervical cancer. Mechanisms postulated for increased cancer risk in diabetes include hyperglycemia, hyperinsulinemia with stimulation of IGF-1 axis, obesity that serves as a common soil hypothesis for both cancer and diabetes as well as other factors such as increased cytokine production. More recently some antidiabetic agents have been thought to increase cancer risk such as insulin glargine, while metformin appears to lower cancer risk. In this review, we present the evidence for the link between diabetes and cancer highlighting the general mechanisms proposed for such a link as well as specific hypotheses for individual cancer. We will also discuss the role of insulin, metformin and other antidiabetic agents in cancer risk.